Buckfire and Buckfire 1-800-606-1717
Call Now To Speak With
Michigan's Best Birth Injury Lawyers

Continuous intrathecal baclofen therapy in children with cerebral palsy – when does improvement emerge?

Posted on November 13th 2009

Conclusion: There seems to be a sequence of changes after introduction of continuous intrathecal baclofen in a child with cerebral palsy that may guide the multidisciplinary team in their timing of therapy during post-surgical follow-up. (Source: Acta Paediatrica)

  • Print this article!
  • E-mail this story to a friend!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • FriendFeed
  • LinkedIn
  • Propeller
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • TwitThis

Related posts:

  1. [Intrathecal baclofen therapy : Overdose during replacement of a medication pump.]
  2. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study
  3. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment
  4. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006
  5. Report Shows Constraint-Induced Movement Therapy May Improve Arm Use In Children With Hemiplegic Cerebral Palsy



Categories: Michigan Birth Injury News | | Permalink | Trackback | Print This Post Print This Post | Email This Post Email This Post

Comments are closed.